France has placed itself firmly at the forefront of research into
personalised medical solutions for cancer, infectious diseases and
rare genetic diseases by investing nearly half a billion euros into
the ADNA project.
Scientists have come up with an innovative tool that may accelerate
the drug development process, which has slowed down considerably
despite the investment in new technologies and analytical